Real-time Estimate
Other stock markets
|
5-day change | 1st Jan Change | ||
876.6 DKK | +1.14% | +1.02% | +25.34% |
Apr. 25 | NOVO NORDISK : JP Morgan gives a Buy rating | ZD |
Apr. 25 | Scholz promises support for pharma sector in Germany as Merck invests | RE |
Sales 2024 * | 287B 41.35B | Sales 2025 * | 346B 49.74B | Capitalization | 3,867B 556B |
---|---|---|---|---|---|
Net income 2024 * | 104B 14.9B | Net income 2025 * | 125B 17.96B | EV / Sales 2024 * | 13.5 x |
Net Debt 2024 * | 23.85B 3.43B | Net cash position 2025 * | 348M 50.12M | EV / Sales 2025 * | 11.2 x |
P/E ratio 2024 * |
37.5
x | P/E ratio 2025 * |
30.9
x | Employees | 63,845 |
Yield 2024 * |
1.36% | Yield 2025 * |
1.62% | Free-Float | 70.47% |
Latest transcript on Novo Nordisk A/S
1 day | +0.55% | ||
1 week | +0.59% | ||
Current month | -1.13% | ||
1 month | -1.91% | ||
3 months | +19.03% | ||
6 months | +28.80% | ||
Current year | +24.81% |
Managers | Title | Age | Since |
---|---|---|---|
Chief Executive Officer | 58 | 90-12-31 | |
Director of Finance/CFO | 53 | 98-12-31 | |
Stephen Gough
CTO | Chief Tech/Sci/R&D Officer | - | 15-09-30 |
Members of the board | Title | Age | Since |
---|---|---|---|
Sylvie Grégoire
BRD | Director/Board Member | 63 | 15-03-18 |
Helge Lund
CHM | Chairman | 61 | 17-03-22 |
Martin MacKay
BRD | Director/Board Member | 68 | 18-02-28 |
Name | Weight | AuM | 1st Jan change | Investor Rating |
---|---|---|---|---|
21.31% | 192 M€ | +12.55% | ||
10.45% | 5 M€ | +7.05% | ||
5.40% | 18 M€ | +3.79% | - | |
4.67% | 88 M€ | +10.37% | - |
Date | Price | Change | Volume |
---|---|---|---|
24-04-26 | 875 | +0.95% | 623 416 |
24-04-25 | 866.8 | -1.35% | 2,439,240 |
24-04-24 | 878.7 | -1.41% | 1,877,505 |
24-04-23 | 891.3 | +1.83% | 1,866,811 |
24-04-22 | 875.3 | +1.05% | 2,031,675 |
Delayed Quote Nasdaq Copenhagen, April 26, 2024 at 04:50 am EDT
More quotesEPS Revisions
1st Jan change | Capi. | |
---|---|---|
+24.81% | 556B | |
-6.33% | 354B | |
+19.90% | 331B | |
+7.95% | 296B | |
+13.28% | 233B | |
+5.54% | 201B | |
-10.06% | 193B | |
-12.26% | 143B | |
-6.47% | 144B | |
+1.01% | 123B |
- Stock Market
- Equities
- NOVO B Stock